Developments in the systemic therapy of pancreatic cancer.

el-Rayes, B F; Shields, A F; Vaitkevicius, V; Philip, P A

el-Rayes, B F; Shields, A F; Vaitkevicius, V; Philip, P A.

Affiliation

el-Rayes BF; Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R Street, Detroit, MI 48201, USA.

Cancer Invest ; 21(1): 73-86, 2003.

Article in En | MEDLINE | ID: mdl-12643012

Subject(s)

Adenocarcinoma/therapy; Deoxycytidine/analogs & derivatives; Pancreatic Neoplasms/therapy; Adenocarcinoma/drug therapy; Adenocarcinoma/mortality; Adenocarcinoma/pathology; Adenocarcinoma/radiotherapy; Angiogenesis Inhibitors/therapeutic use; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Deoxycytidine/administration & dosage; Diagnostic Imaging; Drug Design; Drug Resistance, Neoplasm; Enzyme Inhibitors/therapeutic use; Fluorouracil/administration & dosage; Fluorouracil/therapeutic use; Humans; Neoplasm Proteins/antagonists & inhibitors; Palliative Care; Pancreatectomy; Pancreatic Neoplasms/drug therapy; Pancreatic Neoplasms/mortality; Pancreatic Neoplasms/pathology; Pancreatic Neoplasms/radiotherapy; Signal Transduction/drug effects; Topoisomerase I Inhibitors; United States/epidemiology; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Deoxycytidine Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Cancer Invest Year: 2003 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links